mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.06 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.06 |
mRNA |
skepinone-L |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.06 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.06 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.06 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |